Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of oral prednisolone on inflammatory cell counts in nasal polyps
RBR-6s8q37zCompleted
- Sponsor
- Universidade Federal de Pernambuco
- Start
- Jan 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of prednisolone in chronic rhinosinusitis with nasal polyps (CRSwNP) and nasal polyp, sponsored by Universidade Federal de Pernambuco. Primary endpoint: Inflammatory cell counts in nasal polyp tissue. Started Jan 2025; status: completed.
02
Drugs
prednisolone
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)nasal polyp
Beyond the preview
Go deeper on RBR-6s8q37z.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6s8q37z.